Division of Infectious Diseases

The Weekly Corona with Dr. Raquel Lamarche

Dr. Raquel Lamarche is a PGY1 Internal Medicine/Pediatrics resident at UNMC, who will be summarizing updates about SARS-CoV-2 and hopefully make information easier to digest, with additional outlines of implications for graduate medical education. This week Dr. Lamarche discusses “The reopening”. You can follow Dr. Lamarche on Twitter @LamarcheRaquel.

COVID-19 disproportionately impacts minority communities

The COVID-19 pandemic has changed lives all over the world, responsible for over 4 million infections and over 300,000 deaths worldwide. As we have progressed through this pandemic, it has become clear in the United States that we need to begin and continue conversations relating to the disturbing racial/ethnic disparities we are seeing emerging from cases, hospitalizations, and death due to COVID-19. We have identified… Continue Reading

The Weekly Corona with Dr. Raquel Lamarche

Dr. Raquel Lamarche is a PGY1 Internal Medicine/Pediatrics resident at UNMC, who will be summarizing updates about SARS-CoV-2 and hopefully make information easier to digest, with additional outlines of implications for graduate medical education. This week Dr. Lamarche discusses a pediatric Infectious Diseases primer. You can follow Dr. Lamarche on Twitter @LamarcheRaquel.

The Weekly Corona with Dr. Raquel Lamarche

Dr. Raquel Lamarche is a PGY1 Internal Medicine/Pediatrics resident at UNMC, who will be summarizing updates about SARS-CoV-2 and hopefully make information easier to digest, with additional outlines of implications for graduate medical education. This week Dr. Lamarche discusses “Wellness in the time of COVID-19”. You can follow Dr. Lamarche on Twitter @LamarcheRaquel.

A critical examination of the controversial study behind hydroxychloroquine and azithromycin for COVID-19

On March 20th, the International Journal of Antimicrobial Agents published Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial by Gautret et al.  The president of the United States tweeted about the article the very next day, and on March 28th the FDA announced an emergency use authorization to allow the distribution of hydroxychloroquine and chloroquine from national stockpiles… Continue Reading